Related references
Note: Only part of the references are listed.TET2, ASXL1, IDH1, IDH2, and c-CBL genes in JAK2-and MPL-negative myeloproliferative neoplasms
Luz Martinez-Aviles et al.
ANNALS OF HEMATOLOGY (2012)
Inactivation of polycomb repressive complex 2 components in myeloproliferative and myelodysplastic/myeloproliferative neoplasms
Joannah Score et al.
BLOOD (2012)
ASXL1 mutations in primary and secondary myelofibrosis
Clara Ricci et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients
T. L. Lasho et al.
LEUKEMIA (2012)
SF3B1, a splicing factor is frequently mutated in refractory anemia with ring sideroblasts
V. Visconte et al.
LEUKEMIA (2012)
Deletion of the tumor-suppressor gene NF1 occurs in 5% of myeloid malignancies and is accompanied by a mutation in the remaining allele in half of the cases
C. Haferlach et al.
LEUKEMIA (2012)
Primary myelofibrosis: 2012 update on diagnosis, risk stratification, and management
Ayalew Tefferi
AMERICAN JOURNAL OF HEMATOLOGY (2011)
ASXL1 mutations identify a high-risk subgroup of older patients with primary cytogenetically normal AML within the ELN Favorable genetic category
Klaus H. Metzeler et al.
BLOOD (2011)
Disruption of the ASXL1 gene is frequent in primary, post-essential thrombocytosis and post-polycythemia vera myelofibrosis, but not essential thrombocytosis or polycythemia vera: analysis of molecular genetics and clinical phenotypes
Brady L. Stein et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
DIPSS Plus: A Refined Dynamic International Prognostic Scoring System for Primary Myelofibrosis That Incorporates Prognostic Information From Karyotype, Platelet Count, and Transfusion Status
Naseema Gangat et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
DNMT3A mutations in myeloproliferative neoplasms
F. Stegelmann et al.
LEUKEMIA (2011)
Concomitant analysis of EZH2 and ASXL1 mutations in myelofibrosis, chronic myelomonocytic leukemia and blast-phase myeloproliferative neoplasms
O. Abdel-Wahab et al.
LEUKEMIA (2011)
DNMT3A mutational analysis in primary myelofibrosis, chronic myelomonocytic leukemia and advanced phases of myeloproliferative neoplasms
O. Abdel-Wahab et al.
LEUKEMIA (2011)
Myeloid blastic transformation of myeloproliferative neoplasms-A review of 112 cases
Syed J. Noor et al.
LEUKEMIA RESEARCH (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Somatic SF3B1 Mutation in Myelodysplasia with Ring Sideroblasts
E. Papaemmanuil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Rare mutations in DNMT3A in myeloproliferative neoplasms and myelodysplastic syndromes
M. Brecqueville et al.
BLOOD CANCER JOURNAL (2011)
Mutations and deletions of the SUZ12 polycomb gene in myeloproliferative neoplasms
M. Brecqueville et al.
BLOOD CANCER JOURNAL (2011)
Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms
Stephen T. Oh et al.
BLOOD (2010)
Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations
Wen-Chien Chou et al.
BLOOD (2010)
Combined mutations of ASXL1, CBL, FLT3, IDH1, IDH2, JAK2, KRAS, NPM1, NRAS, RUNX1, TET2 and WT1 genes in myelodysplastic syndromes and acute myeloid leukemias
Julien Rocquain et al.
BMC CANCER (2010)
ASXL1 mutation is associated with poor prognosis and acute transformation in chronic myelomonocytic leukaemia
Veronique Gelsi-Boyer et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Genetic Analysis of Transforming Events That Convert Chronic Myeloproliferative Neoplasms to Leukemias
Omar Abdel-Wahab et al.
CANCER RESEARCH (2010)
Sex differences in the JAK2V617F allele burden in chronic myeloproliferative disorders
Brady L. Stein et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Molecular aspects of myeloproliferative neoplasms
Francois Delhhommeau et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2010)
Mutual exclusion of ASXL1 and NPM1 mutations in a series of acute myeloid leukemias
N. Carbuccia et al.
LEUKEMIA (2010)
IDH1 and IDH2 mutation studies in 1473 patients with chronic-, fibrotic- or blast-phase essential thrombocythemia, polycythemia vera or myelofibrosis
A. Tefferi et al.
LEUKEMIA (2010)
Myelodysplastic syndromes: lost between two states?
C. Acquaviva et al.
LEUKEMIA (2010)
IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms
A. Pardanani et al.
LEUKEMIA (2010)
LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations
A. Pardanani et al.
LEUKEMIA (2010)
Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1
A. Tefferi
LEUKEMIA (2010)
Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia
J. Boultwood et al.
LEUKEMIA (2010)
Spectrum of mutations in RARS-T patients includes TET2 and ASXL1 mutations
Hadrian Szpurka et al.
LEUKEMIA RESEARCH (2010)
Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB
Johanna C. Scheuermann et al.
NATURE (2010)
Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes
Gorica Nikoloski et al.
NATURE GENETICS (2010)
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders
Thomas Ernst et al.
NATURE GENETICS (2010)
DNMT3A Mutations in Acute Myeloid Leukemia.
Timothy J. Ley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent CBL mutations associated with 11q acquired uniparental disomy in myeloproliferative neoplasms
Francis H. Grand et al.
BLOOD (2009)
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes
James W. Vardiman et al.
BLOOD (2009)
Janus kinase 2 mutations in Philadelphia negative chronic myeloproliferative disorders: Clinical implications
Anna D. Panani
CANCER LETTERS (2009)
Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies
Hideki Makishima et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Mutations of ASXL1 gene in myeloproliferative neoplasms
N. Carbuccia et al.
LEUKEMIA (2009)
TET2 mutations and their clinical correlates in polycythemia vera, essential thrombocythemia and myelofibrosis
A. Tefferi et al.
LEUKEMIA (2009)
Mutation inTET2in Myeloid Cancers
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Mutation in TET2 in Myeloid Cancers
Francois Delhommeau et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis
Linda M. Scott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
MPLW515L is anovel somatic activating mutation in myelofibrosis with myeloid metaplasia
Yana Pikman et al.
PLOS MEDICINE (2006)
Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor
Yang-Sook Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Characterization of Asxl1, a murine homolog of Additional sex combs, and analysis of the Asx-like gene family
CL Fisher et al.
GENE (2006)
Share Paper
